Skip to content
Skip to footer

Back to McKesson.com Home

Business Services and Solutions

Our integrated approach combines expert advisory services and cutting-edge technology to help you overcome challenges, identify opportunities, and improve your pharmacy’s performance.

Explore
- Professional & Advisory Services
  
  Improve your pharmacy's business performance with McKesson's Professional & Advisory Services (P&AS). By leveraging deep industry knowledge and advanced analytics, we help you improve operations so you can achieve more for the business of pharmacy.
  
  Specialty and Infusion Solutions for Health Systems
  
  Specialty Pharmacy
  
  Payer Solutions
  
  340B Advisory
  
  340B Impact
  
  Contract Concierge
  
  Orphan Drug Support Program
- Additional Business Solutions
  
  Our extensive portfolio of business solutions empowers health system pharmacies to achieve more by improving operations and driving business growth. Leveraging technology-driven platforms and strategic guidance, we provide actionable insights to address critical challenges, including supply chain management, revenue cycle optimization, 340B drug pricing, and more.
  
  Macro Helix™/ RxO
  
  Class of Trade Optimization
  
  SupplyLogix®
  
  EnterpriseRx®
Pharmaceutical Products and Distribution

It's time to expect more from your pharmaceutical distributor. Let us provide the perspective, focus, and execution you need to help the business of pharmacy achieve more for the advancement of patient health. Our innovative distribution strategies and suite of pharmaceutical products empower your health system to focus on your commitment on advancing value-based care.

Explore
- Pharmaceutical Products
  
  Our expansive portfolio is designed to support the continuum of care, from groundbreaking biosimilar innovations and essential generics to life-changing orphan drugs and revolutionary cell and gene therapies. Additionally, our robust supply assurance strategies ensure that you can depend on a consistent and timely delivery of the medications your patients rely on.
  
  Biosimiliars
  
  Branded and Generic Products
  
  Orphan Drugs
  
  Cell, Gene, & Advanced Therapies
  
  Supply Assurance
- McKesson Plasma & Biologics
  
  As demand for specialty pharmaceuticals and biologics continues to rise and add complexity to the supply chain, we’re responding with new distribution strategies to seamlessly deliver. McKesson Plasma and Biologics offers customers an expansive portfolio of plasma-derived products, biologics and other specialty drugs at competitive prices from a single source that has deep experience in specialized patient care. 
- Ordering and Reporting
  
  McKesson's innovative ordering and reporting solutions are designed to help health systems achieve more for the business of pharmacy. Our comprehensive platforms allow your pharmacy to streamline operations, optimize inventory and make data-driven decisions.
  
  McKesson Enterprise Reporting & Analytics (ERA)
  
  Connect Ordering
  
  Rapid Returns
Industry News and Insights

Staying informed on the latest industry news and insights is critical in achieving more for the business of pharmacy. Within Prescribed Perspectives, you’ll find exclusive articles, podcasts, eBooks, research, and additional resources authored by our health system experts that can help your health system pharmacy with operational efficiency, cost-saving strategies, and more.

Explore
- Prescribed Perspectives Insights Center
  
  A dedicated resource for health system teams to access valuable industry insights and cost-saving strategies.
  
  Research
  
  Case Studies
  
  eBooks
  
  Industry Webinars
  
  View All
  
  Subscribe Now
- Our Authors
  
  With unique industry knowledge and first-hand experience across virtually all areas of health system pharmacy, our authors and experts are dedicated to helping you achieve more.
- Insights by Topic
  
  Get straight to the insights that matter most to your health system.
  
  C-Suite Considerations
  
  340B
  
  Specialty Pharmacy
  
  Supply Chain & Distribution
  
  MHS in the News
  
  View All
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.
Contact Health Systems

Ready to achieve more for the business of pharmacy? Contact us today to discover how McKesson's innovative business services and solutions can help improve your operations and drive financial success.

Contact Us Now
- Contact Health Systems
  
  Contact Us
  
  Communications Preference Center
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.

Could Expanding the CGT Network to Include Community Hospitals Ease Capacity Constraints and Improve Patient Access?

As the CGT pipeline grows, the currently CGT delivery model may feel the strain.

By McKesson Health Systems Editorial Team

Date

May 22, 2024

Read time: 4 minutes

By: Joe DePinto

In a recent article published by Cell & Gene and coauthored by Joe DePinto, Head of Cell, Gene, & Advanced Therapies at McKesson, the challenges and future of cell and gene therapy (CGT) access in the U.S. are discussed. With 32 CGT products currently available and a growing pipeline, the healthcare system faces capacity issues. This insightful piece explores the possibility of expanding the healthcare provider network to include community hospitals, which could potentially alleviate capacity constraints and enhance patient care for CGTs. Read the full article, Part 1: Mobilizing Community Hospitals To Improve Patient Access To Cell And Gene Therapies, on Cell & Gene.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Related Stories

Pharmacist in a white coat standing in a pharmacy with shelves of medications in the background.

Giving Pharmacy a Voice in the Health System Strategy

Three McKesson Health Systems pharmacy leaders discuss how data, technology, and patient access strategies are shaping the future of health system pharmacy.

Laptop beside a stack of tabbed documents on a desk with a blurred office background.

Top Prescribed Perspectives Reads of September

The top three Prescribed Perspectives articles most read by health systems in September 2026.

McKesson Wins Vizient’s 2026 Distribution Excellence Award

Vizient's 2026 Distribution Excellence Award honors suppliers that consistently deliver exceptional service and value to Vizient member health systems.

Audience members seated at an event applaud during a presentation, with several attendees visible in a conference setting.

Upcoming Event: THMA Fall Pharmacy Growth Collaborative 2026

Advancing the business of pharmacy through collaboration and shared insights

Four business attendees walk through a modern office lobby carrying work bags and luggage, with glass walls and seating in the background.

Upcoming Event: HOSP 2026 Annual Meeting

Connect with McKesson at HOSP to help advance the future of specialty pharmacy

Pharmacist standing behind a pharmacy counter, reviewing paperwork beside a computer and medication shelves.

Keeping Care Connected: Closing Visibility Gaps in Specialty Pharmacy

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Related Tags